Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure

HPB

Volumn 12, Issue 5, 2010, Pages 325-333

  Aslani, Alireza ^a   Gill, Anthony J ^b   Roach, Paul J ^a   Allen, Barry J ^a   Smith, Ross C ^c  

^a Department of Nuclear Medicine ^*  (Australia)

^b CENTRAL SYDNEY AREA HEALTH SERVICE   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Bioelectrical impedance; Body composition; Body fat; Body protein; Body water; Pancreatic neoplasms; Resection; Surgery; Survival; Whipple's procedure

Indexed keywords

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT MASS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LENGTH OF STAY; MALE; MASS; ORGAN WEIGHT; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PREOPERATIVE EVALUATION; PROTEIN DEFICIENCY; SEX DIFFERENCE; SURVIVAL TIME; TOTAL BODY NITROGEN; TOTAL BODY POTASSIUM; TOTAL BODY WATER;

EID: 77953593288     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00171.x     Document Type: Article

References (44)

1. Bozzetti F, Gianotti L, Braga M, Di Carlo V, Mariani L. (2007) Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr 26:698-709.
2. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117-2127.
3. Cameron JL, Riall TS, Coleman J, Belcher KA. (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244:10-15.
4. Ahmad NA, Lewis JD, Ginsberg GG, Haller DG, Morris JB, Williams NN et al. (2001) Longterm survival after pancreatic resection for pancreatic adenocarcinoma. Am J Gastroenterol 96:2609-2615.
5. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221:721-731.
6. Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. (2005) Longterm survival is superior after resection for cancer in high-volume centres. Ann Surg 242:540-544.
7. Lim JE, Chien MW, Earle CC. (2003) Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 237:74-85.
8. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al. (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210.
9. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al. (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248-257.
10. Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, Buchler MW et al. (2009) Pancreatic cancer-related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 9:255.
11. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME. (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12:1193-1201.
12. Allen BJ, Blagojevic N, Delaney I, Pollock CA, Ibels LS, Allman MA et al. (1990) The role of body protein studies in clinical trials. Basic Life Sci 55:155-169.
13. Hansen RD, Allen BJ. (1996) Calibration of a total body potassium monitor with an anthropomorphic phantom. Phys Med Biol 41:2447-2462.
14. Hansen RD, Raja C, Aslani A, Smith RC, Allen BJ. (1999) Determination of skeletal muscle and fat-free mass by nuclear and dual-energy x-ray absorptiometry methods in men and women aged 51-84 y. Am J Clin Nutr 70:228-233.
15. Durnin JV, Womersley J. (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97.
16. Smith RC, Ledgard JP, Doig G, Chesher D, Smith SF. (2009) An effective automated nutrition screen for hospitalized patients. Nutrition 25:309-315.
17. Aslani A, Smith RC, Allen BJ, Pavlakis N, Levi JA. (2000) The predictive value of body protein for chemotherapy-induced toxicity. Cancer 88:796-803.
18. Kushner RF, Schoeller DA. (1986) Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr 44:417-424.
19. Cohn SH, Vartsky D, Yasumura S, Sawitsky A, Zanzi I, Vaswani A et al. (1980) Compartmental body composition based on total-body nitrogen, potassium, and calcium. Am J Physiol 239:524-530.
20. Gill AJ, Johns AL, Eckstein R, Samra JS, Kaufman A, Chang DK et al. (2009) Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology 41:161-167.
21. American Joint Committee on Cancer. (2002) Cancer Staging Manual, 6th edn. New York, NY: Springer.
22. Lin Y, Kikuchi S, Tamakoshi A, Yagyu K, Obata Y, Inaba Y et al. (2007) Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer 120:2665-2671.
23. House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M et al. (2008) Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12:270-278.
24. Gupta R, Ihmaidat H. (2003) Nutritional effects of oesophageal, gastric and pancreatic carcinoma. Eur J Surg Oncol 29:634-643.
25. Niedergethmann M, Shang E, Farag SM, Saar J, Berisha S, Willeke F et al. (2006) Early and enduring nutritional and functional results of pylorus preservation vs. classic Whipple procedure for pancreatic cancer. Langenbecks Arch Surg 391:195-202.
26. Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE et al. (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 143:75-83.
27. Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Forestieri P et al. (2000) Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol 73:212-218.
28. Millikan KW, Deziel DJ, Silverstein JC, Kanjo TM, Christein JD, Doolas A et al. (1999) Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 65:618-623.
29. Moon HJ, An JY, Heo JS, Choi SH, Joh JW, Kim YI. (2006) Predicting survival after surgical resection for pancreatic ductal adenocarcinoma. Pancreas 32:37-43.
30. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. (1996) Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83:625-631.
31. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586-594.
32. Esposito I, Seiler C, Bergmann F, Kleeff J, Friess H, Schirmacher P. (2007) Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment. Pancreas 35:212-217.
33. Kim J, Reber HA, Dry SM, Elashoff D, Chen SL, Umetani N et al. (2006) Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut 55:1598-1605.
34. Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93:1232-1237.
35. Verbeke CS, Menon KV. (2008) Variability in reporting resection margin status in pancreatic cancer. Ann Surg 247:716-717.
36. Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE et al. (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to longterm survival in pancreatic cancer. J Gastrointest Surg 10:1338-1345.
37. Xue A, Scarlett CJ, Jackson CJ, Allen BJ, Smith RC. (2008) Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma. Pancreas 36:160-167.
38. Marechal R, Demols A, Gay F, De Maertelaere V, Arvanitaki M, Hendlisz A et al. (2007) Prognostic factors and prognostic index for chemonaive and gemcitabine-refractory patients with advanced pancreatic cancer. Oncology 73:41-51.
39. Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, Lammersfeld CA. (2004) Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr 92:957-962.
40. Barbosa-Silva MC, Barros AJ. (2005) Bioelectric impedance and individual characteristics as prognostic factors for postoperative complications. Clin Nutr 24:830-838.
41. Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF et al. (2008) Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer 8:249.
42. Gupta D, Lis CG, Dahlk SL, King J, Vashi PG, Grutsch JF et al. (2008) The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancer. Nutr J 7:19.
43. Andreyev HJ, Norman AR, Oates J, Cunningham D. (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34:503-509.
44. Fearon KC, Voss AC, Hustead DS. (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83:1345-1350.